Email this article Current treatment methods for sarcopenia in patients undergoing hemodialysis
- Authors: Jakovenko A.A.1
-
Affiliations:
- Academician I.P. Pavlov First St. Petersburg State Medical University
- Issue: Vol 8, No 2 (2018)
- Pages: 36-42
- Section: Articles
- URL: https://journals.rcsi.science/uroved/article/view/9116
- DOI: https://doi.org/10.17816/uroved8236-42
- ID: 9116
Cite item
Full Text
Abstract
Aim. To evaluate the effectiveness of combined post-dilution online hemodiafiltration therapy and ketoanalogue amino acid medications at a dose of 0.2 g/kg of ideal body weight/day for sarcopenia-correcting interventions in patients on hemodialysis with adequate intake of essential nutrients.
Materials and methods. In total, 645 patients undergoing hemodialysis were examined. Nutritional status of all patients was evaluated to identify pre-sarcopenia and sarcopenia. In addition, leptin and interleukin-6 serum levels were determined. The patients with signs of sarcopenia were divided into three groups depending on the treatment method.
Results. We demonstrated the effectiveness of combined post-dilution online hemodiafiltration therapy and ketoanalogue amino acids at a dose of 0.2 g/kg of ideal body weight/day for correction of sarcopenia in patients on hemodialysis.
Conclusion. Combined therapy with post-dilution online hemodiafiltration therapy and ketoanalogue amino acids at a dose of 0.2 g/kg of ideal body weight/day is regarded as a pathogenetically grounded method for correction of sarcopenia in patients on hemodialysis with adequate intake of essential nutrients.
Full Text
##article.viewOnOriginalSite##About the authors
Aleksandr A. Jakovenko
Academician I.P. Pavlov First St. Petersburg State Medical University
Author for correspondence.
Email: leptin-rulit@mail.ru
Candidate of Medical Science, Associate Professor, Department of Nephrology and Dialysis
Russian Federation, Saint PetersburgReferences
- Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391-398. doi: 10.1038/sj.ki.5002585.
- Giglio J, Kamimura MA, Lamarca F, et al. Association of Sarcopenia With Nutritional Parameters, Quality of Life, Hospitalization, and Mortality Rates of Elderly Patients on Hemodialysis. J Ren Nutr. 2018;28(3):197-207. doi: 10.1053/j.jrn.2017.12.003.
- Cruz-Jentoft AJ, Baeyenns JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423. doi: 10.1093/ageing/afq034.
- Bataille S, Serveaux M, Carreno E, et al. The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients. Clin Nutr. 2017;36(6):1654-1660. doi: 10.1016/j.clnu.2016.10.016.
- Kittiskulnam P, Chertow GM, Carrero JJ, et al. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017;92(1):238-247. doi: 10.1016/j.kint.2017.01.024.
- Kittiskulnam P, Carrero JJ, Chertow GM, et al. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle. 2017;8(1):57-68. doi: 10.1002/jcsm.12130.
- European best practice guidelines Guideline on Nutrition. Nephrol Dial Transplant. 2007;22(Suppl.2):45-87.
- Supasyndh O, Satirapoj B, Aramwit P, et al. Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients. Clin J Am SocNephrol. 2013;8(2):271-279. doi: 10.2215/CJN.00380112.
- Kopple JD, Cheung AK, Christiansen JS, et al. A large-scale randomized clinical trial of growth hormone in hemodialysis patients. Nephrol Dial Transplant. 2011;26(12):4095-4103. doi: 10.1093/ndt/gfr363.
- Collden G, Tschop MH, Muller TD. Therapeutic Potential of Targeting the Ghrelin Pathway. Int J Mol Sci. 2017;18(4):E798. doi: 10.3390/ijms18040798.
- Alix PM, Guebre-Egziabher F, Soulage CO. Leptin as an uremic toxin: Deleterious role of leptin in chronic kidney disease. Biochimie. 2014;105:12-21. doi: 10.1016/j.biochi.2014.06.024.
- Nube MJ, Peters SAE, Blankestijn PJ, et al. Mortality reduction by post-dilution online-haemodiafiltration: a cause-specific analysis. Nephrol Dial Transplant. 2017;32(3):548-555. doi: 10.1093/ndt/gfw381.
- Molina P, Vizcaino B, Molina MD, et al. The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study. Nephrol Dial Transplant. 2018; [Epub ahead of print]. doi: 10.1093/ndt/gfx342.
- Vega A, Quiroga B, Abad S, et al. Albumin leakage in online hemodiafiltration, more convective transport, more losses? Ther Apher Dial. 2015;19(3):267-271. doi: 10.1111/1744-9987.12247.
